Boston Scientific Corporation BSX
Set alert
At close · Oct 30
After hours · Oct 30, 7:55 PM ET
- YTD
- -55.97%
- 1 year
- -58.26%
- Open
- 42.95
- Prev close
- 42.69
- Mkt cap
- 60.84B
- Vol
- 22.47M
- Avg vol
- 19.54M
- EPS
- 2.37
- P/E
- 17.71
- Div yield
- 0.00%
More statistics
- Low
- 41.73
- High
- 43.28
- Forward P/E
- 13.16
- Beta
- 0.57
- Short ratio
- 2.17
- Inst. own
- 94.93%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 3, 2027
- 50-d avg
- 44.94
- 200-d avg
- 56.78
- 1y target
- 51.53
5D chart
Events in this range
- Oct 28, 2026Earnings: 0.73; estimate 0.727; surprise 0.41%
- Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 29, 2026Rating: Bernstein · Outperform → Outperform
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 29, 2026Downgrade: Jefferies · Buy → Hold
- Oct 30, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 30, 2026Downgrade: TD Cowen · Buy → Hold
Signals (98)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:40 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:00 PM | 2 days ago |
| RSI: Oversold | Oct 30, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:25 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:20 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| RSI: Overbought | Oct 29, 3:30 PM | 3 days ago |
| RSI: Overbought | Oct 29, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:40 PM | 4 days ago |
| RSI: Overbought | Oct 28, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:10 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 5 days ago |
| RSI: Overbought | Oct 26, 3:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:25 PM | 6 days ago |
| RSI: Oversold | Oct 26, 1:05 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:20 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:25 AM | 6 days ago |
News
1 day ago zacks.com
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.
-
2 days ago benzinga.com
TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46
TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.
-
2 days ago benzinga.com
Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45
Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
2 days ago 247wallst.com
Buy, Sell, or Hold? Today's Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte.
Pre-Market Stock Futures: Futures are trading lower this Friday, with the Nasdaq down almost 2.
2 days ago zacks.com
New Strong Sell Stocks for October 30th
BSX, NBHC and NMRK have been added to the Zacks Rank #5 (Strong Sell) List on October 30th, 2026.
-
2 days ago benzinga.com
Jefferies Downgrades Boston Scientific to Hold, Lowers Price Target to $46
Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.
-
2 days ago benzinga.com
Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $48
Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $66 to $48.
2 days ago prnewswire.com
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
ALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.
-
3 days ago benzinga.com
RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.
-
3 days ago benzinga.com
Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.
-
3 days ago benzinga.com
Leerink Partners Maintains Outperform on Boston Scientific, Lowers Price Target to $50
Leerink Partners analyst Mike Kratky maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $55 to $50.
-
3 days ago benzinga.com
UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57
UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.
3 days ago zacks.com
BSX Q3 Earnings Call Flags Growth Challenges Through 2027
Boston Scientific faces a challenging 2027 as cybersecurity disruptions, EP and WATCHMAN weakness and China pricing pressures weigh on growth prospects.
-
3 days ago benzinga.com
Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
3 days ago 247wallst.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Boston Scientific, eBay, Fervo Energy, Fortinet, Hilton Worldwide Holdings, Lennox International, Palantir Technologies, and More
Pre-Market Stock Futures: Futures are trading lower after a solid day for the stock market, as the interest-rate scenario played out as we (and most across Wall Street) predicted, with the Federal…
3 days ago benzinga.com
These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results
Boston Scientific Corp (NYSE:BSX) on Wednesday posted upbeat third-quarter financial results and cut its FY26 guidance below estimates.
3 days ago benzinga.com
These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results
Boston Scientific beat Q3 estimates but cut FY26 guidance; Q4 forecasts missed expectations. Analysts adjusted price targets.
-
3 days ago benzinga.com
Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.
-
3 days ago benzinga.com
BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $49
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.
3 days ago marketbeat.com
Boston Scientific Q3 Earnings Call Highlights
Boston Scientific NYSE: BSX reported third-quarter 2026 results that fell below its prior guidance after a cybersecurity incident disrupted manufacturing and product shipments for eight business…
3 days ago fool.com
Boston Scientific: 3 Key Takeaways for Long-Term Investors
An eight-day cyber outage reduced third-quarter sales by $150 million. Management expects full-year 2026 organic revenue growth of 4%.
3 days ago fool.com
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
NYSE · As of 4:00 PM ET 10/28/26
-
4 days ago benzinga.com
Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.
4 days ago zacks.com
BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
Boston Scientific's third-quarter revenues beat estimates, but contracting margins, weaker segment sales and reduced 2026 guidance weigh on shares.
4 days ago seekingalpha.com
Boston Scientific Corporation (BSX) Q3 2026 Earnings Call Transcript
Boston Scientific Corporation (BSX) Q3 2026 Earnings Call Transcript
4 days ago benzinga.com
Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance
Boston Scientific slips after a cyber fallout offsets a Q3 consensus beat. Management targets a 2027 cycle trough and 2030 expansion.
4 days ago zacks.com
Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall…
4 days ago benzinga.com
Boston Scientific Q3 2026 Earnings Call Transcript
Boston Scientific (NYSE:BSX) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This content is powered by…
4 days ago zacks.com
Boston Scientific (BSX) Q3 Earnings Match Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.73 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.75 per share a year ago.
4 days ago wsj.com
Boston Scientific Cuts View Again After Cyberattack, Other Challenges
Boston Scientific lowered its outlook, as it expects to end a difficult year with a fourth-quarter sales decline.
4 days ago barrons.com
Boston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hit Its Business.
Boston Scientific cuts full-year guidance as the medical device maker grapples with the fallout of a cyberattack.
-
4 days ago benzinga.com
Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 Est; Lowers FY2026 Sales Guidance from $21.178B-$21.379B to $20.927B vs $21.143B Est
Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 analyst estimate. Lowers FY2026 sales outlook from $21.178 billion-$21.379 billion to $20.927…
-
4 days ago benzinga.com
Boston Scientific Sees Q4 Adj EPS $0.77-$0.79 vs $0.84 Est; Sees Sales $5.127B-$5.233B vs $5.404B Est
Boston Scientific (NYSE:BSX) is looking for Q4 Adj EPS of $0.77-$0.79 vs $0.84 analyst estimate. sees sales of $5.127 billion-$5.233 billion vs $5.404 billion analyst estimate.
-
4 days ago benzinga.com
Boston Scientific Q3 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $5.138B Beat $5.046B Estimate
Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 2.67 percent decrease over earnings of $0.75…
4 days ago prnewswire.com
Boston Scientific announces results for third quarter 2026
MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported,…
4 days ago seekingalpha.com
Brown Advisory Flexible Equity Strategy: Q3 2026 Top Contributors And Detractors
Microsoft Corporation was the portfolio's top contributor during the quarter. Suncor Energy outperformed the Index during the quarter. KLA Corporation traded lower during the quarter.
4 days ago defenseworld.net
Boston Scientific Corporation $BSX Stock Bought by Evergreen Capital Management LLC
Evergreen Capital Management LLC grew its position in shares of Boston Scientific Corporation (NYSE: BSX) by 236.2% in the third quarter, according to the company in its most recent 13F filing with…
5 days ago benzinga.com
Microsoft, Alphabet On Deck Wednesday As AI Spending, Cloud Growth Face Test
Microsoft and Alphabet headline Wednesday’s reports, with investors weighing whether AI infrastructure spending is translating into durable cloud and advertising growth. GE Vernova, Amphenol, Banco…
5 days ago defenseworld.net
Boston Scientific Corporation $BSX Stock Bought by Citizens Financial Group Inc. RI
Citizens Financial Group Inc. RI lifted its position in Boston Scientific Corporation (NYSE: BSX) by 183.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities…
-
6 days ago benzinga.com
Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.
6 days ago prnewswire.com
Boston Scientific to participate in Stifel's 2026 Healthcare Conference
MARLBOROUGH, Mass., Oct. 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026.
-
2 weeks ago benzinga.com
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.
3 weeks ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48
Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.
-
3 weeks ago benzinga.com
Boston Scientific Appoints Joseph M. Fitzgerald As EVP And COO, Effective January 1, 2027
Fitzgerald currently serves as executive vice president and group president, Cardiovascular, Boston Scientific. Under his leadership, the company has strengthened its portfolio through organic…
4 weeks ago benzinga.com
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.13% on an annualized basis producing an average annual return of 14.35%. Currently, Boston Scientific has a market…
-
1 month ago benzinga.com
Elutia Obtains $8M Payment from Boston Scientific; Co. Now Fully Funded into 2029
Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced it has received the full $8 million held in escrow in connection with the sale…
1 month ago benzinga.com
FDA Flags Boston Scientific Catheter Recall
Boston Scientific recalls Imager II Angiographic Catheters over tip detachment defect. Learn about patient risks & FDA safety updates.
-
1 month ago benzinga.com
Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $48
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $50 to $48.
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…